Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Argus Health
Teva
Queensland Health
Cantor Fitzgerald
US Department of Justice
Healthtrust
Deloitte

Generated: April 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE RECOMBINANT

« Back to Dashboard

INSULIN GLARGINE RECOMBINANT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC N 0088-2219-00
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC N 0088-2219-05
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC N 0088-2220-33
Sanofi Aventis Us LANTUS insulin glargine recombinant INJECTABLE;INJECTION 021081 NDA sanofi-aventis U.S. LLC N 0088-5020-05
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Colorcon
Harvard Business School
Fuji
Citi
Mallinckrodt
Johnson and Johnson
Baxter
Cipla